UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 147

Sortiert nach

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Clinical cancer research, 2016-12, Vol.22 (23), p.5772-5782

2016

Link zum Volltext

Verfügbarkeit prüfen

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

Blood, 2016-09, Vol.128 (13), p.1671-1678

2016

Link zum Volltext

Verfügbarkeit prüfen

‘Double‐Hit’ cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients

British journal of haematology, 2014-08, Vol.166 (3), p.369-374

2014

Link zum Volltext

Verfügbarkeit prüfen

Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach

Scientific reports, 2024-02, Vol.14 (1), p.4922-4922, Article 4922

2024

Link zum Volltext

Verfügbarkeit prüfen

DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia

Clinical cancer research, 2015-04, Vol.21 (7), p.1614-1620

2015

Link zum Volltext

Verfügbarkeit prüfen

A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia

PloS one, 2016-04, Vol.11 (4), p.e0153016-e0153016

2016

Link zum Volltext

Verfügbarkeit prüfen

Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing

PloS one, 2016-04, Vol.11 (4), p.e0152851-e0152851

2016

Link zum Volltext

Verfügbarkeit prüfen

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Nature communications, 2017-08, Vol.8 (1), p.319-11, Article 319

2017

Link zum Volltext

Verfügbarkeit prüfen

Greater expectations: meeting clinical needs through broad and rapid genomic testing

Clinical chemistry and laboratory medicine, 2023-03, Vol.61 (4), p.654

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience

Endocrine pathology, 2016-12, Vol.27 (4), p.359-362

2016

Link zum Volltext

Verfügbarkeit prüfen

PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma

Endocrine pathology, 2015-12, Vol.26 (4), p.365-369

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice

Modern pathology, 2021-05, Vol.34 (5), p.904-921

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline POT1 variants can predispose to myeloid and lymphoid neoplasms

Leukemia, 2022-01, Vol.36 (1), p.283-287

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma

Academic pathology, 2019, Vol.6, p.2374289519848353-2374289519848353, Article 2374289519848353

2019

Link zum Volltext

Verfügbarkeit prüfen

STK11 Mutation Identified in Thyroid Carcinoma

Endocrine pathology, 2016-03, Vol.27 (1), p.65-69

2016

Link zum Volltext

Verfügbarkeit prüfen

Jagged1 (JAG1) mutations in patients with tetralogy of fallot or pulmonic stenosis

Human mutation, 2010-05, Vol.31 (5), p.594-601

2010

Link zum Volltext

Verfügbarkeit prüfen

Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia

Blood advances, 2019-05, Vol.3 (10), p.1581-1585

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

Breast cancer research and treatment, 2017-08, Vol.164 (3), p.627-638

2017

Link zum Volltext

Verfügbarkeit prüfen

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

The Journal of clinical investigation, 2016-10, Vol.126 (10), p.3814-3826

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(137)

Publikationsform

Artikel
(145)
Berichte
(2)

Sprache

Englisch
(147)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Life Sciences & Biomedicine
(96)
Humans
(81)
Oncology
(45)
Female
(44)
Male
(37)
Mutation
(35)
Middle Aged
(29)
Adult
(25)
Hematology
(25)
Aged
(23)
Pathology
(23)
Genetics & Heredity
(22)
Tumors
(18)
Leukemia, Myeloid, Acute - Genetics
(13)
Prognosis
(13)
Cancer
(12)
Genomics
(12)
Patients
(12)
Animals
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

‘Double‐Hit’ cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients

Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approach

DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia

A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia

Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer

T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

Greater expectations: meeting clinical needs through broad and rapid genomic testing

Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience

PTEN and TP53 Mutations in Oncocytic Follicular Carcinoma

EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma

Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice

Germline POT1 variants can predispose to myeloid and lymphoid neoplasms

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma

STK11 Mutation Identified in Thyroid Carcinoma

Jagged1 (JAG1) mutations in patients with tetralogy of fallot or pulmonic stenosis

Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia

Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

Suchergebnisse filtern